Sims-Williams Hugh P, Javed Shazia, Pickering Anthony E, Patel Nikunj K
North Bristol NHS Trust, Southmead Hospital, University of Bristol, Bristol, UK.
Stereotact Funct Neurosurg. 2016;94(3):174-81. doi: 10.1159/000446608. Epub 2016 Jun 21.
Several deep brain stimulation (DBS) targets have been explored for the alleviation of trigeminal anaesthesia dolorosa. We aimed to characterise the analgesia produced from the periaqueductal grey (PAG) and centromedian-parafascicular (CmPf) nucleus using a within-subject design.
We report a case series of 3 subjects implanted with PAG and CmPf DBS systems for the treatment of anaesthesia dolorosa. At follow-up, testing of onset and offset times, magnitude, and thermal and mechanical sensitivity was performed.
The mean pain score of the cohort was acutely reduced by 56% (p < 0.05) with PAG and 67% (p < 0.01) with CmPf stimulation at mean time intervals of 38 and 16 min, respectively. The onset time was 12.5 min (p < 0.05) for PAG stimulation and 2.5 min (p < 0.01) for CmPf. The offset time was 2.5 min (p < 0.05) for PAG and 12.5 min (p < 0.01) for CmPf. The two targets were effective at different stimulation frequencies and were not antagonistic in effect.
The mechanisms by which stimulation at these two targets produces analgesia are likely to be different. Certain pain qualities may respond more favourably to specific targets. Knowledge of onset and offset times for the targets can guide optimisation of stimulation settings. The use of more than one stimulation target may be beneficial and should be considered in anaesthesia dolorosa patients.
为缓解三叉神经痛性麻木,人们已经探索了多个脑深部电刺激(DBS)靶点。我们旨在采用受试者自身对照设计来描述中脑导水管周围灰质(PAG)和中央中-束旁核(CmPf)产生的镇痛效果。
我们报告了一个病例系列,3名受试者植入了用于治疗痛性麻木的PAG和CmPf DBS系统。在随访时,对起效和失效时间、强度以及热和机械敏感性进行了测试。
在平均时间间隔分别为38分钟和16分钟时,PAG刺激使该队列的平均疼痛评分急剧降低了56%(p<0.05),CmPf刺激使其降低了67%(p<0.01)。PAG刺激的起效时间为12.5分钟(p<0.05),CmPf刺激的起效时间为2.5分钟(p<0.01)。PAG刺激的失效时间为2.5分钟(p<0.05),CmPf刺激的失效时间为12.5分钟(p<0.01)。这两个靶点在不同的刺激频率下起作用,且作用并非相互拮抗。
这两个靶点的刺激产生镇痛的机制可能不同。某些疼痛性质可能对特定靶点反应更良好。了解靶点的起效和失效时间可指导刺激参数的优化。使用多个刺激靶点可能有益,在痛性麻木患者中应予以考虑。